The Patent Finder

A & G Pharmaceutical, Inc.

Also on record
Records under this name other than the patents A & G Pharmaceutical, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.

Back to A & G Pharmaceutical, Inc.

PatentTitleStatus Expires Confidence
US 7,674,460Compositions and methods for restoring sensitivity to treatment with HER2 antagonists
Term ended
Term ended Apr 12, 2026 · From the USPTO record
Term endedTerm ended Apr 12, 2026From the USPTO record
US 7,815,906Compositions and methods for restoring sensitivity to treatment with HER2 antagonists
Term ended
Term ended Oct 26, 2024 · From the USPTO record
Term endedTerm ended Oct 26, 2024From the USPTO record
US 7,651,854Methods for increasing the proliferation of B cells
Term ended
Term ended Oct 17, 2024 · From the USPTO record
Term endedTerm ended Oct 17, 2024From the USPTO record
US 7,560,095Cancer specific monoclonal antibodies
Term ended
Term ended Aug 7, 2024 · From the USPTO record
Term endedTerm ended Aug 7, 2024From the USPTO record
US 7,411,045Autocrine growth factor receptor antibodies and methods
Term ended
Term ended Jun 14, 2024 · From the USPTO record
Term endedTerm ended Jun 14, 2024From the USPTO record
US 7,368,428Compositions and methods for restoring sensitivity of tumor cells to antitumor therapy and inducing apoptosis
Lapsed on the fee record
Ended May 6, 2020 · From the USPTO record
Lapsed on the fee recordEnded May 6, 2020From the USPTO record
US 7,183,384Monoclonal antibody 7H11 reactive with human cancer
Lapsed on the fee record
Ended Feb 27, 2019 · From the USPTO record
Lapsed on the fee recordEnded Feb 27, 2019From the USPTO record
US 7,091,047Methods and kits for diagnosing tumorigenicity
Term ended
Term ended Aug 2, 2018 · From the USPTO record
Term endedTerm ended Aug 2, 2018From the USPTO record
US 7,592,31888kDa tumorigenic growth factor and antagonists
Term ended
Term ended Jul 6, 2018 · From the USPTO record
Term endedTerm ended Jul 6, 2018From the USPTO record
US 6,824,77588kDa tumorigenic growth factor and antagonists
Term ended
Term ended Jun 24, 2018 · From the USPTO record
Term endedTerm ended Jun 24, 2018From the USPTO record
10 of 17 patents shown.
Pro members see all 17.
Pro members: see all 17 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited